Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential

Sreeharsha Gurrapu1, Emanuela Pupo2, Giulia Franzolin1,3

  • 1Cancer Cell Biology Laboratory, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.

Insights

Semaphorin 4C (Sema4C) signaling drives breast cancer growth and metastasis. Inhibiting Sema4C or its receptor PlexinB2 halts tumor cell proliferation and invasiveness, revealing a potential therapeutic target.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Signaling

Background:

  • Semaphorin 4C (Sema4C) expression is linked to poor outcomes in human breast cancers.
  • The role of Sema4C in breast cancer progression, particularly in luminal-type cancers, requires further elucidation.

Purpose of the Study:

  • To investigate the functional role of Semaphorin 4C (Sema4C) and its receptor PlexinB2 in breast cancer cell growth, phenotype, and metastasis.
  • To identify the underlying molecular mechanisms of Sema4C/PlexinB2 signaling in breast carcinoma.

Main Methods:

  • Knock-down experiments of Sema4C and PlexinB2 in mammary carcinoma cell lines.
  • Analysis of cell cycle progression, cytokinesis, and senescence.
  • Investigation of RhoA-GTP levels and downstream signaling pathways.
  • Assessment of phenotypic changes including cell polarity, migration, and invasiveness.
  • In vivo studies using mouse models of estrogen-independent metastatic tumors.

Main Results:

  • Sema4C/PlexinB2 signaling is crucial for maintaining RhoA-GTP levels, essential for cancer cell proliferation.
  • Inhibition of Sema4C/PlexinB2 leads to growth arrest, cell cycle defects, and senescence in carcinoma cells.
  • Sema4C upregulation induces phenotypic changes promoting invasiveness and metastasis, including altered cell polarity and increased transcription factors like Snail, Slug, and SOX-2.
  • Sema4C-overexpressing cells form estrogen-independent metastatic tumors in vivo.
  • The signaling cascade involves ErbB2 and RhoA-dependent kinases.

Conclusions:

  • Sema4C/PlexinB2 signaling is a critical driver of breast carcinoma cell growth and represents a novel therapeutic target.
  • Elevated Sema4C expression promotes the transition of indolent luminal breast cancers to an aggressive, metastatic phenotype, potentially explaining its association with poor prognosis.

Related Concept Videos

Contact-dependent Signaling01:19

Contact-dependent Signaling

Contact-dependent signaling, as the name suggests, requires that communicating cells be in direct contact with each other. This is achieved either through receptor-ligand interactions or by specialized cytoplasmic channels that allow the flow of small molecules between cells. In animal cells, channels called gap junctions facilitate contact-dependent signaling in certain tissues, whereas, plasmodesmata perform a similar function in plants.
Gap Junctions
In animal cells, gap junctions are formed...
47.6K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
84.2K
Plant Hormones01:56

Plant Hormones

Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.7K
Cell-surface Signaling01:21

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.7K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.3K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.0K